NettetLilach Lerman Background: Percutaneous transluminal renal angioplasty (PTRA) improves blood pressure (BP) and renal function only in selected patients with … NettetLilach O. Lerman, M.D., Ph.D., studies the pathophysiology of renovascular disease, high blood pressure (hypertension) and cardiac adaptation. In particular, Dr. Lerman's lab is focused on finding better ways to treat the narrowing of arteries that carry blood to the kidneys (renal artery stenosis), which can cause hypertension.
CiteSeerX — Human Carotid Atherosclerosis
NettetAmir Lerman focuses on Internal medicine, Cardiology, Coronary artery disease, Endothelium and Endothelial dysfunction. As a member of one scientific family, Amir Lerman mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, In vivo. Nettet©˜2012 Landes Bioscience. Do not distribute. Impaired myocardial autophagy linked to energy metabolism disorders Zi-Lun Li1,2 and Lilach O. Lerman1,3,* 1Division of Nephrology and Hypertension; Mayo Clinic; Rochester, MN USA; 2Division of Vascular Surgery; the First Affiliated Hospital; Sun Yat-sen University; Guangzhou, China; … depth criterion
Lilach O. Lerman Mayo Clinic 633 Publications 29750 Citations ...
Nettet4. jun. 2024 · Cellular senescence, an irreversible growth arrest in response to a noxious milieu, is characterized by release of proinflammatory cytokines. We hypothesized that … Nettet8. apr. 2024 · Harriet Dustan Award Council for High Blood Pressure Research. 2013. Mayo Clinic Regenerative Medicine. 2010. Novel Methodology Award Mayo Clinic. … Nettet31. okt. 2024 · EVs from ccRCC cell lines (786-O, RCC53, Caki1, and Caki2) and patient tissues were isolated via ultracentrifugation. EVs were characterized using transmission electron microscopy, nanoparticle tracking analysis, and Western blotting using exosome and putative tumor markers (epithelial cell adhesion molecule (EpCAM), carbonic … depth crusher calamity